Indefinite Delivery Contract SPM20005D3109
- Not listed
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at up to $4,999,999.00, is for the provision of pharmaceutical and medical supplies to support the DLA's Pharmaceutical Prime Vendor program. The contract allows for multiple delivery orders to be issued over the performance period, which runs through June 30,...
- This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company, to provide a wide range of pharmaceutical and medical supplies to the U.S. federal government. The single-award IDC has a ceiling value of $9,999,999,999.00 and a period of performance through May 31, 2015. Cardinal Health delivers products such as antibiotics, pain medications, vaccines, radiopharmaceuticals, and specialty drugs...
- This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a major healthcare services and products company, to provide pharmaceutical and medical supply distribution services to the U.S. federal government. The single-award contract, valued at an unspecified ceiling, has a period of performance from January 25, 2005, through March 31, 2015. The contract aims to supply a comprehensive range of medical products, including prescription...
- The provided information outlines an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large, for-profit healthcare services and products company. The contract, valued at $0, is for the supply of a wide range of pharmaceutical and medical products, including prescription medications, over-the-counter drugs, vaccines, and radiopharmaceuticals, to various government agencies such as the Department of Defense (DoD), Department of Veterans...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Defense's Medical Supply Chain agency to Cardinal Health, Inc., a global healthcare services and products company. The contract, valued at up to $4,999,999.00, is for the provision of pharmaceutical, medical, and radiopharmaceutical products to support federal healthcare agencies such as the Department of Veterans Affairs (VA), Department of Defense (DoD), and National Institutes of Health (NIH). The contract is...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a large for-profit healthcare services and products company, to provide a wide range of pharmaceutical and medical supplies to the Department of Defense (DoD), Department of Veterans Affairs (VA), and other federal agencies. The contract, valued at an undisclosed ceiling amount, covers the delivery of products such as prescription medications, over-the-counter drugs, vaccines,...
- This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The single-award IDC has a ceiling value of $4,999,999 and a period of performance through June 7, 2027. It is intended to provide a flexible procurement mechanism for the DLA and other Department of Defense (DoD) customers to rapidly acquire a wide range of medical supplies under Federal Supply Group 46 and Federal Supply Class 6515....
- The Indefinite Delivery Contract (IDC) SPE2DM20D9103, awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., aims to provide a wide range of medical and pharmaceutical products to support military treatment facilities and DoD customers in DLA Region 1. The single-award IDC, with a ceiling value of $4,999,999, runs through August 2027 and allows for the rapid procurement of surgical dressings, drugs, biologicals, and other medical...
- This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Defense's Defense Logistics Agency (DLA) to Cardinal Health, Inc., a global healthcare services and products company. The single-award IDC has a ceiling value of $95,000,000 and a period of performance from July 1, 2015, to June 30, 2025. The contract primarily aims to provide a wide range of pharmaceutical, medical, and radiopharmaceutical products to federal agencies, including the Department of Veterans Affairs...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $4,999,999 and covers the supply of a wide range of medical and pharmaceutical products to military treatment facilities, Veterans Affairs hospitals, and other government healthcare providers. The contract does not have any small business set-asides. The IDC enables the rapid procurement of essential...
- SPM20005D3109Indefinite Delivery Contract
- 2.2KFederal Contract Awards
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Cardinal Health, Inc., a major healthcare services and products company, to provide pharmaceutical and medical supplies to the U.S. federal government. The contract has a ceiling value of $0.00 and was awarded on January 25, 2005 with a period of performance through March 31, 2015. Under this IDC, Cardinal Health has received numerous firm fixed-price delivery orders to supply a variety of pharmaceutical and medical products, including antibiotics, pain medications, vaccines, specialty drugs, and radiopharmaceuticals, to the Department of Defense, Department of Veterans Affairs, National Institutes of Health, and other federal agencies. The delivery orders, ranging in value from a few dollars to over $30,000, cover the provision of these products to military treatment facilities, VA healthcare centers, and other government medical facilities across the United States. The contract does not utilize any set-asides, reflecting Cardinal Health's status as a large, for-profit corporation. The company has also participated in a limited number of federal grant sub-awards, such as the distribution of naloxone under a COVID-19 supplemental grant.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 1/25/05 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPM20005D3109-C348 | Cardinal Health, Inc. | $4.5k | 4/18/15 | 4/20/15 | 4/18/15 | |
Delivery Order SPM20005D3109-C367 | Cardinal Health, Inc. | $1.4k | 5/14/15 | 5/18/15 | 5/14/15 | |
Delivery Order SPM20005D3109-AV69 | Cardinal Health, Inc. | $9.5k | 12/9/09 | 12/9/09 | 12/9/09 | |
Delivery Order SPM20005D3109-C108 | Cardinal Health, Inc. | $25.2k | 1/10/15 | 1/12/15 | 1/10/15 | |
Delivery Order SPM20005D3109-BZ33 | Cardinal Health, Inc. | $6.9k | 10/1/14 | 10/1/14 | 10/1/14 |